InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to ...

InMode (INMD) has just issued fresh revenue guidance, outlining expectations of US$103.6 million to US$103.8 million for Q4 2025, US$370.2 million to US$370.4 million for 2025, and US$365 million to ...

The firm is scheduled to report its financial performance for Q4 and fiscal 2025 ahead of the market open on Tuesday, Feb. 10 ...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term InMode Ltd. (NASDAQ:INMD) shareholders know that all too well, since the share price is down considerably ...

InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues.

InMode is a small-cap medical device company that invented a new way to do plastic surgery in a non-invasive way, via radio waves. The company is dominating its niche market, and the stock is up ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode, known for radiofrequency microneedling technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve ...

Inmode ((INMD)) has held its Q3 earnings call. Read on for the main highlights of the call. InMode’s recent earnings call revealed a mixed sentiment, with positive developments in international ...

InMode has been a great investment over the past two years, but it's going through a slump right now. Treatments with InMode's cosmetic devices tend to be less expensive than the alternatives.

InMode is growing its revenue at an impressive rate. The company's profit margins are very high and improving. InMode makes medical devices that emit radio frequencies, a minimally and (in some cases) ...